132 related articles for article (PubMed ID: 37306437)
1. Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an
Garisetti V; Dhanabalan AK; Dasararaju G
J Biomol Struct Dyn; 2024 Jun; 42(9):4745-4758. PubMed ID: 37306437
[TBL] [Abstract][Full Text] [Related]
2. Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.
Ye N; Li B; Mao Q; Wold EA; Tian S; Allen JA; Zhou J
ACS Chem Neurosci; 2019 Jan; 10(1):190-200. PubMed ID: 30540906
[TBL] [Abstract][Full Text] [Related]
3. The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
Bi Y; Dzierba CD; Fink C; Garcia Y; Green M; Han J; Kwon S; Kumi G; Liang Z; Liu Y; Qiao Y; Zhang Y; Zipp G; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Westphal RS; Kimball D; Bronson JJ; Macor JE
Bioorg Med Chem Lett; 2015 Apr; 25(7):1443-7. PubMed ID: 25754495
[TBL] [Abstract][Full Text] [Related]
4. Effect of Substitution on the Aniline Moiety of the GPR88 Agonist 2-PCCA: Synthesis, Structure-Activity Relationships, and Molecular Modeling Studies.
Jin C; Decker AM; Harris DL; Blough BE
ACS Chem Neurosci; 2016 Oct; 7(10):1418-1432. PubMed ID: 27499251
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88.
Decker AM; Gay EA; Mathews KM; Rosa TC; Langston TL; Maitra R; Jin C
J Biomed Sci; 2017 Mar; 24(1):23. PubMed ID: 28347302
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, pharmacological characterization, and structure-activity relationship studies of small molecular agonists for the orphan GPR88 receptor.
Jin C; Decker AM; Huang XP; Gilmour BP; Blough BE; Roth BL; Hu Y; Gill JB; Zhang XP
ACS Chem Neurosci; 2014 Jul; 5(7):576-87. PubMed ID: 24793972
[TBL] [Abstract][Full Text] [Related]
7. Benchmarking GPCR homology model template selection in combination with de novo loop generation.
Szwabowski GL; Castleman PN; Sears CK; Wink LH; Cole JA; Baker DL; Parrill AL
J Comput Aided Mol Des; 2020 Oct; 34(10):1027-1044. PubMed ID: 32737667
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Structure-Activity Relationship Studies of Novel GPR88 Agonists (4-Substituted-phenyl)acetamides Based on the Reversed Amide Scaffold.
Rahman MT; Guan D; Chaminda Lakmal HH; Decker AM; Imler GH; Kerr AT; Harris DL; Jin C
ACS Chem Neurosci; 2024 Jan; 15(1):169-192. PubMed ID: 38086012
[TBL] [Abstract][Full Text] [Related]
9.
Muthiah I; Rajendran K; Dhanaraj P; Vallinayagam S
J Biomol Struct Dyn; 2021 Aug; 39(13):4807-4815. PubMed ID: 32580684
[TBL] [Abstract][Full Text] [Related]
10. Orphan G protein-coupled receptors: The role in CNS disorders.
Alavi MS; Shamsizadeh A; Azhdari-Zarmehri H; Roohbakhsh A
Biomed Pharmacother; 2018 Feb; 98():222-232. PubMed ID: 29268243
[TBL] [Abstract][Full Text] [Related]
11. Modeling and Deorphanization of Orphan GPCRs.
Diaz C; Angelloz-Nicoud P; Pihan E
Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
[TBL] [Abstract][Full Text] [Related]
12. Activation and allosteric regulation of the orphan GPR88-Gi1 signaling complex.
Chen G; Xu J; Inoue A; Schmidt MF; Bai C; Lu Q; Gmeiner P; Liu Z; Du Y
Nat Commun; 2022 May; 13(1):2375. PubMed ID: 35501348
[TBL] [Abstract][Full Text] [Related]
13. The Orphan GPCR Receptor, GPR88, Interacts with Nuclear Protein Partners in the Cerebral Cortex.
Rebeillard F; De Gois S; Pietrancosta N; Mai TH; Lai-Kuen R; Kieffer BL; Giros B; Massart R; Darmon M; Diaz J
Cereb Cortex; 2022 Jan; 32(3):479-489. PubMed ID: 34247243
[TBL] [Abstract][Full Text] [Related]
14. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
[TBL] [Abstract][Full Text] [Related]
15. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
Bermudez M; Wolber G
Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
[TBL] [Abstract][Full Text] [Related]
16. A novel G-protein-coupled receptor gene expressed in striatum.
Mizushima K; Miyamoto Y; Tsukahara F; Hirai M; Sakaki Y; Ito T
Genomics; 2000 Nov; 69(3):314-21. PubMed ID: 11056049
[TBL] [Abstract][Full Text] [Related]
17. Protection of Primary Dopaminergic Midbrain Neurons Through Impact of Small Molecules Using Virtual Screening of GPR139 Supported by Molecular Dynamic Simulation and Systems Biology.
Kaushik AC; Gautam D; Nangraj AS; Wei DQ; Sahi S
Interdiscip Sci; 2019 Jun; 11(2):247-257. PubMed ID: 31177377
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological validation of a novel radioligand for the orphan GPR88 receptor.
Decker AM; Rahman MT; Kormos CM; Hesk D; Darcq E; Kieffer BL; Jin C
Bioorg Med Chem Lett; 2023 Jan; 80():129120. PubMed ID: 36587872
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel G-protein-coupled receptor 40 (GPR40) agonists by hybrid
Nath V; Ahuja R; Kumar V
J Biomol Struct Dyn; 2019 Sep; 37(14):3764-3787. PubMed ID: 30252605
[TBL] [Abstract][Full Text] [Related]
20. The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs.
Laboute T; Gandía J; Pellissier LP; Corde Y; Rebeillard F; Gallo M; Gauthier C; Léauté A; Diaz J; Poupon A; Kieffer BL; Le Merrer J; Becker JA
Elife; 2020 Jan; 9():. PubMed ID: 32003745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
